These findings confirm the prediction that sensitizing non-responders downstream of the caspase-8/caspase-3/Bid triad is the most effective means to enhance apoptosis responsiveness in otherwise TRAIL/TL32711 resistant GBM cells. Here, BID is linked to glioblastoma.